Focused Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-384
| Closed | -$297K | – | 285 |
|
|
2026
Q1 | $297K | Buy |
+384
| New | +$294K | 0.03% | 157 |
|
|
2024
Q2 | – | Sell |
-112
| Closed | -$108K | – | 258 |
|
|
2024
Q1 | $108K | Buy |
112
+101
| +918% | +$96K | 0.02% | 177 |
|
|
2023
Q4 | $9.44K | Sell |
11
-15
| -58% | -$12.4K | ﹤0.01% | 563 |
|
|
2023
Q3 | $21.2K | Sell |
26
-43
| -62% | -$33.8K | ﹤0.01% | 417 |
|
|
2023
Q2 | $49.6K | Hold |
69
| – | – | 0.01% | 304 |
|
|
2023
Q1 | $56.7K | Hold |
69
| – | – | 0.01% | 285 |
|
|
2022
Q4 | $49.8K | Hold |
69
| – | – | 0.01% | 308 |
|
|
2022
Q3 | $48K | Hold |
69
| – | – | 0.01% | 285 |
|
|
2022
Q2 | $41K | Buy |
69
+15
| +28% | +$9.75K | 0.01% | 309 |
|
|
2022
Q1 | $38K | Hold |
54
| – | – | 0.01% | 343 |
|
|
2021
Q4 | $34K | Hold |
54
| – | – | 0.01% | 417 |
|
|
2021
Q3 | $33K | Hold |
54
| – | – | 0.01% | 434 |
|
|
2021
Q2 | $30K | Hold |
54
| – | – | 0.01% | 451 |
|
|
2021
Q1 | $26K | Hold |
54
| – | – | ﹤0.01% | 462 |
|
|
2020
Q4 | $26K | Buy |
54
+45
| +500% | +$24.3K | 0.01% | 423 |
|
|
2020
Q3 | $5K | Sell |
9
-150
| -94% | -$91K | ﹤0.01% | 609 |
|
|
2020
Q2 | $99K | Buy |
159
+150
| +1,667% | +$85.1K | 0.02% | 229 |
|
|
2020
Q1 | $4K | Hold |
9
| – | – | ﹤0.01% | 553 |
|
|
2019
Q4 | $3K | Hold |
9
| – | – | ﹤0.01% | 626 |
|
|
2019
Q3 | $2K | Sell |
9
-120
| -93% | -$35.5K | ﹤0.01% | 641 |
|
|
2019
Q2 | $40K | Buy |
129
+120
| +1,333% | +$40K | 0.01% | 340 |
|
|
2019
Q1 | $4K | Hold |
9
| – | – | ﹤0.01% | 577 |
|
|
2018
Q4 | $3K | Sell |
9
-2,109
| -100% | -$772K | ﹤0.01% | 596 |
|
|
2018
Q3 | $856K | Sell |
2,118
-124
| -6% | -$47.2K | 0.29% | 61 |
|
|
2018
Q2 | $773K | Buy |
+2,242
| New | +$701K | 0.27% | 60 |
|
|
2016
Q4 | – | Sell |
-10
| Closed | -$4K | – | 730 |
|
|
2016
Q3 | $4K | Hold |
10
| – | – | ﹤0.01% | 556 |
|
|
2016
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 570 |
|
|
2016
Q1 | $4K | Hold |
10
| – | – | ﹤0.01% | 510 |
|
|
2015
Q4 | $5K | Buy |
+10
| New | +$5.42K | ﹤0.01% | 513 |
|
Other funds holding REGN
Focused Wealth Management's REGN Position: Q2 2026 in Review
Focused Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 384 shares — an estimated $297K sold.
Focused Wealth Management first reported a position in REGN in Q4 2015 and held it in 29 quarters. The position peaked at $856K in Q3 2018. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Focused Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Focused Wealth Management sold 384 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $297K.
- Focused Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 29 quarters.
- Focused Wealth Management's Regeneron Pharmaceuticals position peaked at $856K in Q3 2018.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.